Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Ruffier d'Epenoux

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
The Journal of Arthroplasty|July 5, 2025
Synovial Biomarkers C-Reactive Protein and Calprotectin for Diagnosing Chronic Periprosthetic Joint Infection: A Prospective Multicenter EvaluationLouise Ruffier d'Epenoux, Manon Robert, Raphaël Lecomte, et al.
BMC Infectious Diseases|June 19, 2024
Unusual Cutibacterium acnes splenic abscess with bacteremia in an immunocompetent man: phylotyping and clonal complex analysisAngèle Roudeau, Stéphane Corvec, Beate Heym, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 20, 2024
Ciprofloxacin-susceptible but levofloxacin-resistant Pseudomonas aeruginosa clinical strains with Vitek<sup>®</sup>2: which mechanism involved and consequences in case of fluoroquinolone treatment?Manon Robert, Louise Ruffier d'Epenoux, Axelle Paquin, et al.
International Journal of Dermatology|May 18, 2024
Biofilm of Cutibacterium acnes: a target of different active substancesLouise Ruffier d'Epenoux, Erwan Fayoux, Joëlle Veziers, et al.
Emerging Infectious Diseases|February 26, 2024
Staphylococcus succinus Infective Endocarditis, FranceLouise Ruffier d'Epenoux, Erwan Fayoux, Frédéric Laurent, et al.
Clinical Case Reports|March 27, 2023
Synovial calprotectin: A potentially useful biomarker for the diagnosis of <i>Kingella kingae</i> native arthritisAnne-Gallë Leroy, Pascale Bémer, Cyrille Decante, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2024
Efficacy and safety of co-trimoxazole in device-related bone and joint infections: a CRIOGO multicentre case-control studyRaphaël Lecomte, Colin Deschanvres, Amandine Le Bourgeois, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2025
A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics modelEmmanuel Enard, Matthieu Grégoire, Éric Dailly, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2024
Comparative effectiveness of empirical antibiotic treatments in methicillin-susceptible Staphylococcus aureus infective endocarditis: A post hoc analysis of a prospective French cohort studyRaphaël Lecomte, Colin Deschanvres, Alexis Bourreau, et al.
Future Microbiology|February 1, 2023
<i>In vitro</i> susceptibility of nonfermenting Gram-negative rods to meropenem-vaborbactam and delafloxacinEric Farfour, Louise Ruffier d'Epenoux, Anaëlle Muggeo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
The Journal of Arthroplasty|July 5, 2025
Synovial Biomarkers C-Reactive Protein and Calprotectin for Diagnosing Chronic Periprosthetic Joint Infection: A Prospective Multicenter EvaluationLouise Ruffier d'Epenoux, Manon Robert, Raphaël Lecomte, et al.
BMC Infectious Diseases|June 19, 2024
Unusual Cutibacterium acnes splenic abscess with bacteremia in an immunocompetent man: phylotyping and clonal complex analysisAngèle Roudeau, Stéphane Corvec, Beate Heym, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 20, 2024
Ciprofloxacin-susceptible but levofloxacin-resistant Pseudomonas aeruginosa clinical strains with Vitek<sup>®</sup>2: which mechanism involved and consequences in case of fluoroquinolone treatment?Manon Robert, Louise Ruffier d'Epenoux, Axelle Paquin, et al.
International Journal of Dermatology|May 18, 2024
Biofilm of Cutibacterium acnes: a target of different active substancesLouise Ruffier d'Epenoux, Erwan Fayoux, Joëlle Veziers, et al.
Emerging Infectious Diseases|February 26, 2024
Staphylococcus succinus Infective Endocarditis, FranceLouise Ruffier d'Epenoux, Erwan Fayoux, Frédéric Laurent, et al.
Clinical Case Reports|March 27, 2023
Synovial calprotectin: A potentially useful biomarker for the diagnosis of <i>Kingella kingae</i> native arthritisAnne-Gallë Leroy, Pascale Bémer, Cyrille Decante, et al.
The Journal of Antimicrobial Chemotherapy|September 17, 2024
Efficacy and safety of co-trimoxazole in device-related bone and joint infections: a CRIOGO multicentre case-control studyRaphaël Lecomte, Colin Deschanvres, Amandine Le Bourgeois, et al.
The Journal of Antimicrobial Chemotherapy|August 13, 2025
A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics modelEmmanuel Enard, Matthieu Grégoire, Éric Dailly, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 1, 2024
Comparative effectiveness of empirical antibiotic treatments in methicillin-susceptible Staphylococcus aureus infective endocarditis: A post hoc analysis of a prospective French cohort studyRaphaël Lecomte, Colin Deschanvres, Alexis Bourreau, et al.
Future Microbiology|February 1, 2023
<i>In vitro</i> susceptibility of nonfermenting Gram-negative rods to meropenem-vaborbactam and delafloxacinEric Farfour, Louise Ruffier d'Epenoux, Anaëlle Muggeo, et al.
Pageof 2